Clincosm LogoSign in Get a demo

TinCat LGBTQ+ Smoking Cessation Via Asynchronous Telehealth

Sponsor
University of Texas at Austin (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05499364
Collaborator
(none)
30
Enrollment
2
Arms
5.9
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the efficacy of a novel telehealth-based intervention to reduce tobacco use among LGBTQ+ people.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: TinCat
  • Behavioral: Quit.gov program
 N/A

Detailed Description

After being informed about potential risks and screened into the study, patients will be randomized into the treatment or control group. Control group participants will complete 7 sessions based on quit.gov smoking cessation planning. Intervention participants will complete 7 sessions of individualized asynchronous telehealth sessions.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be assigned to the control or intervention groups randomly.Participants will be assigned to the control or intervention groups randomly.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
TinCat Tobacco Cessation Protocol for LGBTQ+ Austinites
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Quit.gov program

Generic intervention based on quit.gov sessions.

Behavioral: Quit.gov program
7-10 minute generic videos directing participants through quit.gov program
Experimental: TinCat

Individualized asynchronous telehealth including LGBTQ+ affirming components.

Behavioral: TinCat
7-10 minute personalized video sessions based in tobacco cessation modules.

Outcome Measures

Primary Outcome Measures

  1. Tobacco use [11 weeks]

    Cigarette and vape assessments based on prior research on vaping/smoking: Cigarette: Today, did you have at least one puff on a cigarette (yes/no) IF YES, THEN How many cigarettes did you smoked (at least one puff) (1-"more than 60"). Vaping: Today, did you use an electronic nicotine delivery system (i.e., a vape containing nicotine), even just one puff? (yes/no) IF YES, THEN How many times they had at least one puff (1 time, 2-5 times, 6-10 times, 11-15 times, 16-20 times, 21-25 times, 26-30 times, 31 or more times).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • Age 18 and over

  • Live in Greater Austin

  • Identify as LGBTQ+

  • Current smokers

  • High speed internet access

Exclusion Criteria:

  • Exceed screener cutoff for suicide risk

  • Exceed screener cutoff for borderline personality disorder

  • Report current active substance use other than tobacco that interferes with functioning

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Texas at Austin

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Michael Parent, Associate professor, University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT05499364
Other Study ID Numbers:
  • STUDY00003092
First Posted:
Aug 12, 2022
Last Update Posted:
Aug 16, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Tobacco Use Disorder

Study Results

No Results Posted as of Aug 16, 2022